Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

CStone's anti-CTLA-4 antibody CS1002 filed for clinical trial approval in Australia

Saturday, December 30, 2017

CStone Pharmaceuticals Suzhou Co Ltd today announced that an investigational new drug IND filing has been submitted to Human Research Ethics Committees of the Ashford Cancer Center in Australia for CS an independentlydeveloped investigational cytotox...

New Menopause Therapy from Fervent Pharmaceuticals to Begin Clinical Trial

Friday, December 29, 2017

Fervent Pharmaceuticals of Greenville has successfully submitted an Investigational New Drug IND application to the US Food and Drug Administration for FP its proprietary lead drug candidate for treating menopause symptoms especially hot flashesA...

Arrowhead Pharmaceuticals Appoints William Waddill to Board of Directors

Thursday, December 28, 2017

Arrowhead Pharmaceuticals Inc announced that the board of directors elected veteran biotechnology executive William Waddill as an independent director of the company with a term beginning effective January It is anticipated that Mr Waddill will ser...

DelMar Pharmaceuticals Announces Fast Track Designation for VAL-083 in Recurrent Glioblastoma

Wednesday, December 27, 2017

DelMar Pharmaceuticals Inc a biopharmaceutical company focused on the development and commercialization of new cancer therapies today announced that the US Food and Drug Administration FDA has granted Fast Track designation for the companys lead prod...

Acerus Receives Notice of Deficiency from Health Canada for Gynoflor™

Tuesday, December 26, 2017

Acerus Pharmaceuticals Corporation today announced that it has received a Notice of Deficiency NOD for its GynoflorTM New Drug SubmissionIn its notice Health Canada requested additional technical information on GynoflorTM in order to complete its...

Orchard Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference

Friday, December 22, 2017

Orchard Therapeutics a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies today announced that Mark Rothera president and chief executive officer will present at the th Annual J...

Janssen Enters Worldwide Collaboration and License Agreement with Chinese Company Legend Biotech

Friday, December 22, 2017

Janssen Biotech Inc Janssen a Janssen Pharmaceutical Company of Johnson Johnson announced today that it has entered into a worldwide collaboration and license agreement with Legend Biotech USA Inc and Legend Biotech Ireland Limited Legend subsidiari...

FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA® in Advanced Renal Cell Carcinoma

Friday, December 22, 2017

Merck KGaA Darmstadt Germany which operates its biopharmaceutical business as EMD Serono in the US and Canada and Pfizer Inc NYSE PFE today announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation for avelum...

Acerus Enters into a Licensing Agreement with Viramal to Commercialize the Elegant™ Franchise in Canada

Thursday, December 21, 2017

Acerus Pharmaceuticals Corporation announced that it has entered into a license development and supply agreement with Viramal Limited Viramal a Londonbased specialty pharmaceutical company developing therapeutics that improve the quality of womens he...

Evox Therapeutics to Collaborate with Boehringer Ingelheim on Exosome-Mediated Drug Delivery

Thursday, December 21, 2017

Evox Therapeutics Ltd a leading exosome therapeutics company announces that it has entered into a research collaboration with Boehringer Ingelheim to investigate exosomemediated delivery of RNAs with high medical relevance to targets for specific dis...